The destruction of amoxycillin by β-lactamase action represents an important mechanism of bacterial resistance to the drug. Data is presented to illustrate that clavulanic acid used in the form of its potassium salt inhibits the amoxycillin destroying action of many different types of β-lactamase for example: the staphylococcal enzyme, the clinically important plasmid mediated enzymes of the TEM, SHV, OXA and PSE types and the chromosomally controlled enzymes produced by Proteus mirabilis and Klebsiella pneumoniae. The mechanisms by which clavulanic acid inhibits β-lactamases and potentiates the antibacterial action of amoxycillin are discussed.
ReadingCColeM. Clavulanic acid: A beta-lactamase-inhibiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother1977; 11:852–857.
2.
HowarthTTBrownAGKingTJ. Clavulanic acid, a novel beta-lactam isolated from Streptomyces clavuligerus; X-ray crystal structure analysis. J Chem Soc Chem Commun1976;226–267.
3.
SykesRBMatthewM. The ß-lactamases of Gram negative bacteria and their role in resistance to ß-lactam antibiotics. J Antimicrob Chemother1976; 2:115–157.
4.
ColeM. Inhibition of ß-lactamases. In Beta Lactamases. Hamilton-MillerJMTSmithJT. eds. London: Academic Press1979;205–289.
5.
ReadingCFarmerTColeM. Results presented at 12th Int Congress Chemother, Florence 1981 Abstract 1039. Full details to be published.
6.
FarmerTReadingC. ß-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Antimicrob Agents Chemother1982; 21:506–508.
7.
ColeM. ‘ß-Lactams’ as ß-lactamase inhibitors. Phil Trans R Soc Lond1980;B289:207–223.
